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Abstract
Background: Infections are the major cause of morbidity and mortality in children with cancer. Gaining a favorable
prognosis for these patients depends on selecting the appropriate therapy, which in turn depends on rapid and
accurate microbiological diagnosis. This study employed real-time PCR (qPCR) to identify the main pathogens
causing bloodstream infection (BSI) in patients treated at the Pediatric Oncology Institute IOP-GRAACC-UNIFESP-Brazil.
Antimicrobial resistance genes were also investigated using this methodology.
Methods: A total of 248 samples from BACTECW blood culture bottles and 99 whole-blood samples collected in tubes
containing EDTA K2 Gel were isolated from 137 patients. All samples were screened by specific Gram probes for
multiplex qPCR. Seventeen sequences were evaluated using gender-specific TaqMan probes and the resistance genes
blaSHV, blaTEM, blaCTX, blaKPC, blaIMP, blaSPM, blaVIM, vanA, vanB and mecA were detected using the SYBR Green method.
Results: Positive qPCR results were obtained in 112 of the blood culture bottles (112/124), and 90 % agreement was
observed between phenotypic and molecular microbial detection methods. For bacterial and fungal identification, the
performance test showed: sensitivity 87 %; specificity 91 %; NPV 90 %; PPV 89 % and accuracy of 89 % when compared
with the phenotypic method. The mecA gene was detected in 37 samples, extended-spectrum β-lactamases were
detected in six samples and metallo-β-lactamase coding genes in four samples, with 60 % concordance between the
two methods. The qPCR on whole blood detected eight samples possessing the mecA gene and one sample
harboring the vanB gene. The blaKPC, blaVIM, blaIMP and blaSHV genes were not detected in this study.
Conclusion: Real-time PCR is a useful tool in the early identification of pathogens and antimicrobial resistance genes
from bloodstream infections of pediatric oncologic patients.
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Background
In recent decades, the successful treatment of malignan-
cies in children and adolescents has been increasing,
with up to 70–80 % of cases having a favorable outcome.
However, immunosuppression resulting from treatment
makes these patients more susceptible to infections, which
are the leading cause of death in this population [1, 2].
In these patients, bacteremia often results from infection
with one or more microorganisms, predominantly mem-
bers of the Enterobacteriaceae, Pseudomonas aeruginosa,
Streptococcus and Staphylococcus [3, 4]. In a Brazilian
study of 46 patients who had undergone chemotherapy,
26 were neutropenic and 53 % had positive blood cultures
(BC) [1]. Another similar study obtained positive BCs
from 41 hospitalized children among a total of 110
patients tested [4]. In Italy, an analysis at 18 centers of 176
episodes of infection found that 123 (64 %) of these cases
occurred in neutropenic children versus 68 (36 %) in
non-neutropenic children [5].
Bacterial isolation using conventional microbiological
techniques rarely exceeds 25 % in children with clinical
signs and laboratory findings suggestive of invasive bacter-
ial infection [6, 7]. It is also worth noting that in 40 % of
children that have a clinical diagnosis of sepsis and 75 %
of high-risk febrile neutropenia cases, the microorganism* Correspondence: milenequiles@yahoo.com.br1Special Laboratory of Clinical Microbiology (LEMC), Federal University of São
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cannot be detected by currently available conventional
microbiological techniques [8].
In this context, the aim of this study was to evaluate
the performance of in-house real time PCR (qPCR), ap-
plied directly to BACTECW bottles and whole blood sam-
ples, for the detection of 17 relevant microorganisms and
10 antimicrobial resistance genes causing bacteremia in
children with cancer. Our hypothesis was that this mo-
lecular method could be an accurate and sensitive method
for early bacteremia diagnosis in this population.
Methods
Patients
We designed a prospective study that was conducted
between October 2010 and June 2012 and involved 137
patients admitted to the Institute of Pediatric Oncology
(IOP-GRAACC, Brazil), which supports children and
adolescents with cancer. Informed consent was obtained
from patients, and the study was approved by the
Clinical Research Ethics Committee of the hospital.
Blood collection and phenotypic bacterial identification
Blood samples were collected as part of the standard
patient care procedures. The criteria for collecting blood
cultures included: fever, defined as a temperature above
38 °C or above 37.5 °C for three consecutive measure-
ments, or suggestive clinical signs of sepsis.
At the onset of fever or in the presence of clinical
symptoms, two sets of BCs were taken from peripheral
venous access or from the central line catheter. Blood-
stream infection (BSI) was defined as the isolation of a
bacterial or fungal pathogen from at least one BC [9].
All episodes of BSI were then sub-classified as a single-
agent (Gram-positive, Gram-negative or fungi) or poly-
microbial. For polymicrobial BSI, two or more pathogens
were isolated from a single BC or at least two separate
BCs, 96 h apart. BCs were performed using the BAC-
TECW 9240 instrument (Becton Dickinson, Microbiology
Systems, Cockeysville, MD, USA). BC bottles were desig-
nated positive after detection of bacterial growth. Samples
were negative when no bacterial growth was detected after
five days incubation. Identification at the species level and
susceptibility testing were performed using the automated
system Phoenix 100 (Becton Dickinson, Microbiology
Systems).
Whole blood samples were collected at the same time
and following the same criteria when possible. These
samples were not analyzed phenotypically but instead
were subjected to molecular assays.
Molecular detection of microorganisms and resistance
genes
Chromosomal DNA was extracted from 500 μl of positive
and negative BC samples after incubation on BACTECW
9240, using the phenol–chloroform method (Brazol; LGC
Biotechnologia, Cotia, Brazil) with 300 mg glass beads
(0.3 mm diameter; Scientific Industries, Bohemia, NY,
USA), and were processed in a disruptor Genie (Scientific
Industries) for 10 min to achieve cell lysis. In parallel,
chromosomal DNA was extracted from 1.5 ml of whole
blood samples using the QIAamp DNA blood kit (Qiagen
Inc., Valencia, CA, USA). Extracted DNA was diluted
(1:10) using DNase/RNase-free distilled water UltraPure
(Invitrogen, Carlsbad, CA, USA) for reducing the inhibitor
reagents in the sample. Extracted DNA was used for the
detection of pathogens and resistance genes by our in-
house qPCR assay.
The primers used for detection of the resistance genes
blaSHV, blaTEM, blaCTX-M, blaIMP, blaSPM, blaVIM, blaKPC,
vanA, vanB and mecA, have been described previously
[8, 10–12], as have the primers and TaqMan probes for
multiplex qPCR detection of Gram-positive (GP) and
Gram-negative (GN) bacteria and specific-species detec-
tion of Enterococcus spp., coagulase negative Staphylo-
coccus (CoNS), S. aureus, Streptococcus pneumoniae,
Escherichia coli, Klebsiella pneumoniae, Enterobacter
cloacae, Proteus mirabilis, Salmonella spp., Serratia
marcescens, Acinetobacter baumannii, Pseudomonas aer-
uginosa, Stenotrophomonas maltophilia, Mycobacterium
tuberculosis, Aspergillus spp., Candida spp. and Fusar-
ium spp. [13, 14]. A primer set for the hemochromatosis
gene (HFE) was designed to be used as an internal con-
trol of DNA extraction. The analytical validations of
these tests have been described previously [14].
The presence of bacterial DNA in the sample was first
screened by a TaqMan-based multiplex qPCR using uni-
versal primers for the 16S rDNA gene for differentiation
between Gram-positive and Gram-negative bacteria.
Species identification was performed by a Taqman-based
monoplex qPCR. Amplification for the TaqMan probe
reaction was performed in a 20 μl reaction volume, using
10 μl TaqMan Universal Master Mix 2× (Applied Biosys-
tems), 5 μl template DNA, 0.5 μM each primer and
0.3 μM probe. The qPCR conditions were as follows:
50 °C for 2 min and 95 °C for 10 min; 40 cycles of 95 °C
for 15 s and 60 °C for 60 s.
Resistance gene amplification by SYBR Green mono-
plex qPCR was performed in a 25 μl reaction mixture
containing 12.5 μl Platinum SYBR Green qPCR Super-
Mix (Invitrogen, Carlsbad, CA, USA), 0.5 μM each
primer, and 5 μl of DNA extracted from samples. The
qPCR conditions were as follows: 50 °C for 2 min and
95 °C for 10 min; 40 cycles of 95 °C for 15 s and 60 °C
for 60 s; and a melting curve step (from 68 °C to 95 °C
in increments of 0.5 °C/s). Metallo-β-lactamase (MβL)
detection was performed by multiplex qPCR [13]. The
ABI 7500 real-time PCR System (Applied Biosystems)
instrument was quantified online and at the endpoint
Quiles et al. BMC Infectious Diseases  (2015) 15:283 Page 2 of 8
with the sequence detection system software (version
2.0; Applied Biosystems).
The number of DNA molecules present in the sample
was determined based on the amount of fluorescence
detected by the qPCR instrument. This quantified fluor-
escence resulted in a Cycle Threshold value (Ct) that
corresponds to the number of amplification cycles re-
quired to obtain a given amount of DNA [15].
Additional tests to confirm the susceptibility profile
Samples with discordant susceptibility profiles between
molecular and phenotypic analyses were subjected to
further testing to confirm the results. For GN samples
with discordant MβL or extended-spectrum β-lactamase
(ESβL) profiles, we conducted a qPCR assay directly
from the clinical strain recovered from our collection of
microorganisms. These strains were stored at −20 °C in
tryptone soya broth containing glycerol and were sub-
cultured on blood agar for isolation. DNA extraction
and qPCR were performed following the protocols
described above.
For methicillin-resistant Staphylococcus strains with
discordant profiles, we performed the qPCR directly
from the clinical strain and confirmed the minimum
inhibitory concentration (MIC) for oxacillin with an E-
testW. The diameter of the zone for cefoxitin was deter-
mined by the disc diffusion test following the Clinical &
Laboratory Standards Institute recommendations [16].
Statistical analysis
Data collection and statistical analysis were performed
using SPSS version 17.0 software (SPSS Inc., Chicago,
IL, USA) and Microsoft Office Excel 2010 (Microsoft,
Redmond, WA, USA). Comparison of the BC identifica-
tion by phenotypic methods versus qPCR results was
evaluated by χ2 tests. Discordance between the results
from the two methods was assessed using McNemar’s
test (statistical significance was set at a two-tailed exact
test, based on a binomial distribution with p = q = 0.5).
The κ statistic was calculated to measure the level of
agreement between phenotypic and qPCR results dir-
ectly from BC bottles.
Results
A total of 347 samples from 137 patients admitted to
the IOP/GRAACC were included in this study. These
samples included 248 BC bottles and 99 whole blood
samples collected in EDTA tubes. Clinical data from pa-
tients were collected by the Center of Infection Control
at the Institute. Among these 248 BC bottles, 53.2 %
(n = 132) were obtained from peripheral venous access
and 46.8 % (n = 116) from the central line catheter.
The average age of patients was nine years old (ran-
ging from 0 to 25); 64 (46 %) were female and 74 (54 %)
were male. Underlying diseases were blastoma (19 %),
acute lymphoblastic leukemia (15 %), general tumors
(15 %), sarcoma (13 %) and non-Hodgkin lymphoma
(12 %). Among 137 patients, 17 were submitted for allo-
geneic bone marrow transplant, 15 for autologous bone
marrow transplant and one for liver transplantation.
Sulfamethoxazole and trimethoprim antibiotic prophy-
laxis was used in patients with leukemia, lymphoma and
in those with a solid tumor who received corticosteroids
above 2 mg/kg.
Phenotypic testing
Initial phenotypic analyses from 248 BCs identified 127
(51.2 %) negative and 121 (48.8 %) positive samples.
Three episodes were classified as polymicrobial with two
agents detected in one sample. Thus, a total of 124
strains were identified by this method: 67 (54.0 %) GP,
43 (34.7 %) GN species. The main pathogens identified
were CoNS (n = 35) and P. aeruginosa (n = 14) (Table 1).
Fungi species were detected in 14 (11.3 %) samples and
the main agent identified was Candida spp. (n = 12).
The susceptibility testing performed on positive samples
detected 31 (88 %) methicillin-resistant CoNS, 8 (66 %)
methicillin-resistant S. aureus and two vancomycin-
resistant E. faecium. Nine ESβL Enterobacteriaceae pro-
ducers and 12 carbapenem-resistant P. aeruginosa strains
were detected among the GN strains.
Molecular testing from BC bottles
All samples included in the study were positive for the
HFE gene, which indicated that the DNA had been suc-
cessfully extracted. qPCR for GP/GN 16S rDNA from
the 248 BCs samples detected 112 (90.3 %) positive sam-
ples versus the 124 detected by BC processing. Among
69 GP and 42 GN strains identified by BC, the qPCR
method was able to identify 58 (86.5 %) GP and 40
(95.2 %) GN samples (Table 1). The overall concordance
between the phenotypic and molecular methods was
89 % for GP and 90 % for GN detection with a Cohen κ
coefficient of 0.775 (p-value < 0.001 and 95 % CI:
0.651–0.899).
Since the qPCR assay applied in this study was stan-
dardized to detect 17 different species from clinical sam-
ples, 24 samples containing different species were not
identified. The species identified were 15 non-fermenter
bacteria, 18 Enterobacteriaceae, 32 CoNS, 10 S. aureus,
one Streptococci and five Enterococci (Table 1). There
was a discrepancy for one sample that was identified as
S. aureus by the phenotypic method and as CoNS by
qPCR. The molecular method did not identify four GP
samples. One false-positive sample was detected by
qPCR with a 12,703 Ct rate, and this was identified as
CoNS. Candida species were identified in 3 (25 %)
samples.
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For real-time PCR directly from BC bottles the per-
formance test showed: sensitivity 90 %; specificity 88 %;
negative predictive value (NPV) 88 %; positive predictive
value (PPV) 90 % and accuracy of 89 % for GP and GN
detection when compared with the phenotypic method
from BC bottles. For bacterial and fungal identification
the performance test showed: sensitivity 87 %; specificity
91 %; NPV 90 %; PPV 89 % and accuracy of 89 % when
compared with the phenotypic method.
The qPCR for resistance genes detected four Entero-
bacteriaceae strains possessing the blaCTX gene. Three
of these samples were positive for the phenotypic detec-
tion of ESβL while one sample was ESβL negative and
cephalosporin susceptible as determined by phenotypic
analysis. In one ESβL-producer K. pneumoniae strain,
the qPCR detected both blaTEM and blaCTX genes. One
ESβL E. coli strain was identified that contained the bla-
TEM gene. Four carbapenem-resistant P. aeruginosa were
positive for the blaSPM gene. Other GN resistant genes
were not detected. The molecular method was not able
to detect any resistance genes from eight carbapenem-
resistant P. aeruginosa strains and six samples with an
ESβL profile. The concordance between molecular and
phenotypic analysis of the susceptibility profile was 60 %.
Among GP strains, 37 methicillin-resistant samples
were detected that possessed the mecA gene (30 CoNS
and seven S. aureus). There was a discrepancy for three
samples. The concordance between both methods was
92.5 %. Two vancomycin-resistant Enterococci were
positive for the vanA gene with 100 % concordance.
Eight carbapenem-resistant P. aeruginosa isolates that
tested negative for resistance genes on qPCR were sub-
jected to qPCR directly from the clinical strain. Three of
these samples were positive for blaSPM in the second
test. The other five isolates remained negative for resist-
ance genes. One E. coli BC sample that tested positive
for the blaCTX gene and showed susceptibility to all cefa-
losporins was negative for this gene when tested directly
from the isolate.
Three discordant Staphylococcus samples were sub-
jected to confirmatory tests. Two methicillin-resistant
strains (one CoNS and one S. aureus) that were negative
for the mecA gene when tested from BC bottles, tested
mecA positive in the qPCR directly from the isolated
strain. One S. aureus sample considered phenotypically
susceptible to methicillin tested positive for mecA both
from BC bottles and the isolated strain. All three sam-
ples showed a high MIC for this drug and were resistant
in the disc diffusion test.
Molecular analysis of whole blood samples
A total of 99 whole blood samples were analyzed in this
study. A positive result was obtained for the 16S rDNA
qPCR in 12 (12.1 %) samples, of which two were
Table 1 Comparison of phenotypic and molecular assays apllied to bloodculture bottles
Phenotipyc detection and
identification by phenotypic




Concordance (%) Molecular identification
by specific-species qPCR
(n= 124)
Concordance (%) Average Cycle
threshold
S. aureus 12 12 100 % 10 83.40 % 17,683
SCoN 35 28 80 % 32 91.40 % 20,608
Enterococcus
spp.
5 5 100 % 5 100 % 24,923
S. pneumoniae 1 1 100 % 1 100 % 20,977
K. pneumoniae 3 3 100 % 3 100 % 29,111
E. cloacae 6 6 100 % 6 100 % 20,919
E. coli 8 7 87.50 % 7 87.50 % 18,995
S. marcescens 2 2 100 % 2 100 % 25,252
P. aeruginosa 14 13 92.80 % 13 92.80 % 19,395
S. malthofilia 1 1 100 % 1 100 % 36,974
Acinetobacter
spp.
1 1 100 % 1 100 % 27,993
Candida spp. 12 12 100 % 3 25 % 25,464
Other fungi 2 2 100 % a a a
Streptococcus
sp.
9 7 77.80 % a a a
Others 13 12 92.30 % a a a
aSpecies not included in the in-house qPCR standardized assay described in this study
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amplified for both GP and GN and 10 only for GP
(Table 2). The concordance between the phenotypic
analysis of paired BCs of these samples and whole blood
was 67.7 %.
The qPCR for specific species identified CoNS (n = 25),
S. aureus (n = 2), Enterococcus spp. (n = 2), S. pneumoniae
(n = 1), E. coli (n = 1), P. aeruginosa (n = 1) and Candida
spp. (n = 1) with 55 % concordance with phenotypic
identification from paired BCs. One sample showed a
discrepancy with phenotypic detection of E. cloacae and
qPCR detection of S. aureus and CoNS. We identified 14
false-positive samples from qPCR, one Candida spp. and
13 CoNS. This technique was not able to detect eight
positive samples (8.1 %).
The mecA gene was identified from 11 samples of
which three were methicillin-resistant on BC with 60 %
concordance. The vanA gene was detected in one
vancomycin-resistant sample. Other resistance genes
were not detected from whole blood samples. The de-
gree of concordance between the phenotypic susceptibil-
ity test from paired BCs and qPCR from whole blood
was 59 %.
The overall concordance between the qPCR from BC
bottles and whole blood samples was 82 % with a Cohen
K coefficient of 0.702 (p-value < 0.001 and 95 % CI:
0.502 e 0.903).
Discussion
Patients with cancer, especially children, are susceptible
to various infections because of immunosuppression
caused by the treatment. These infections are difficult to
treat and the agent is only identified in 22–39 % of cases
[17]. Effective identification of the causative agent and
the correct choice of antimicrobial therapy is crucial for
reducing mortality in these patients [7].
When conventional techniques are used to identify
bacteria and fungi, only up to 25 % of the episodes of
bacteremia are detected in children with clinical and
laboratory findings. In approximately 40 % of children
diagnosed with sepsis and 75 % with neutropenia, the
microorganism is not detected. Several studies have sug-
gested that applying molecular methods directly to clinical
samples could be a rapid and accurate tool for diagnosis in
these patients [7]. In this study, we compared phenotypic
Table 2 Phenotypic and molecular results from whole blood samples and paired BC bottles






qPCR from BC bottles
for resistance genes (ct)
qPCR from whole blood
for resistance genes (ct)
195 176 S. aureus Oxacillin S mecA (21,855) mecA (33,021)
178 117 a a ND mecA (34,520)
190 152 E. coli Carbapenem S ND ND
191 174 P. aeruginosa Carbapenem S ND ND
283 133 E. cloacae Carbapenem S ND ND
391 255 P. putida Carbapenem S ND ND
404 232 Enterococcus sp Vancomicyn S ND ND
341 233 S. aureus Oxacillin R mecA (28,550) mecA (31,653)
371 240 B. cepacia Carbapenem S ND ND
400 252 B. cepacia Carbapenem S ND ND
477 288 S. epidermidis Oxacillin R mecA (23,914) mecA (33,211)
389 237 E. coli Carbapenem S ND ND
369 244 SCoN Oxacillin S ND mecA (33,073)
372 247 P. aeruginosa Carbapenem S ND ND
373 254 S. epidermidis Oxacillin R mecA (15,683) mecA (29,909)
392 241 S. haemolyticus Oxacillin R mecA (20,648) mecA (37,468)
431 276 SCoN Oxacillin R mecA (15,902) mecA (37,320)
465 293 P. aeruginosa Carbapenem R ND ND
441 273 S. epidermidis Oxacillin R ND ND
422 264 S. aureus Oxacillin R mecA (16,508) mecA (35,945)
423 265 SCoN Oxacillin R mecA (15,513) mecA (36,217)
470 290 E. faecium Vancomicyn R vanA (17,560) vanA (24,938)
BC Bloodculture bottle, ct cycle threshold, R resistant, S Susceptible, ND Not detected
aNegative sample at Phenotypic tests
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and molecular assays for the detection and identification
of microorganisms from clinical samples and performed
susceptibility testing.
We observed that the molecular method was not able
to detect 13 samples (three GN and nine GP) that were
detected by BC processing and 16 samples were not
identified at the species level. Other studies have also
reported discordant results when comparing two or more
methodologies for bacterial detection and identification
from clinical samples [17]. These discrepancies may be
caused by the presence of substances such as heme, IgG,
sodium polyanethol sufonate or hemocomponents, in
clinical samples or BACTECW bottles [18, 19].
One false positive result was identified as GP and
CoNS by qPCR assays with a Ct rate of 12,793. This pa-
tient gave a positive BC result with CoNS two days later,
suggesting that the infection was also present in the pre-
vious sample but was not detectable by the phenotypic
method. Similar results have been reported in other
studies in which pathogens detected only by PCR were
also present in other samples from the same patient that
tested negative on phenotypic testing [20, 21].
The results obtained using the qPCR and phenotypic
methods for determining methicillin susceptibility showed
discrepancies in three S. aureus samples. One S. aureus
sample was detected as methicillin susceptible, but the
mecA gene was detected by qPCR. The other two samples
were methicillin resistant, but the mecA gene was not de-
tected in BC samples. When qPCR was performed directly
from the clinical isolate strains and confirmatory tests for
methicillin susceptibility were conducted, these three sam-
ples were determined to be methicillin resistant. These
findings illustrated the fact that both phenotypic and mo-
lecular methods were not 100 % accurate at determining
the susceptibility profile of clinical samples. The correl-
ation between detection of methicillin resistance by the
phenotypic method and detection of the mecA gene by
SeptiFastW was evaluated in a recent study and the mo-
lecular method was unable to detect the mecA gene in
two samples. The authors suggested that this was due to
the difference in sensitivity between the two tests: one was
conducted directly from clinical samples and the other
directly from the isolates [22].
The phenotypic results of susceptibility tests of GN iso-
lates compared with the qPCR results showed discrepan-
cies in ESβL detection for six samples. In this study we
did not evaluate the presence of the enzyme groups VEB,
GES, PER, and OXA, which can eventually be found com-
posing the same integron and are sporadically reported in
some countries in South America [23–25].
Five carbapenem-resistant samples were detected in this
study that were negative for the MβL-coding gene blaSPM,
even when analyzing the clinical isolate. A Brazilian
study reported a rate of 81.1 % carbapenem-resistant
P. aeruginosa strains that were non-MβL producing
[26]. Another study conducted at the same institution
demonstrated that isolates of P. aeruginosa resistant
to carbapenems that lacked MβL production had been de-
tected in their hospital since 2000, and they proposed that
other resistance mechanisms may be involved, such as
changes in permeability through the membrane, porin loss
or efflux systems [27].
The qPCR assay is not sufficiently comprehensive to
detect all of the possible mechanisms of resistance
expressed by microorganisms. However, because it is an
“in-house” method, it is possible to customize the assay
by adding or deleting genes to be tested depending on
the particular resistance mechanisms of interest.
Our molecular method was able to detect the presence
of fungi DNA in 100 % of samples determined to be
positive by the phenotypic method (n = 14), however, it
was only able to detect the specific species in three sam-
ples of Candida spp. It has previously been suggested
that some positive samples may not be detected by com-
mercial kits because the concentration of microorgan-
isms in BC bottles is usually less than 100 CFU/mL [28].
Molecular analysis of whole blood directly was able to
detect 12.1 % of GP/GN positive samples. The qPCR
also detected one vancomycin-resistant E. faecium sam-
ple containing vanA and 11 mecA positive samples, of
which six gave the same result using the automated sys-
tem. A study conducted with 23 episodes of febrile neu-
tropenia in children detected the presence of bacterial
DNA in three cases (13 %) by culture and in 11 cases
(48 %) by PCR [29]. In another study conducted in Chile
of children with cancer in which molecular detection of
three species (S. aureus, P. aeruginosa and E. coli)
directly from whole blood was performed, the authors
reported a positivity rate of 20 % [7].
Some authors have reported higher sensitivity for de-
tecting pathogens directly from whole blood [7, 30] and
suggest that the volume of blood collected is highly
dependent upon the weight of the patient. They con-
cluded that it is necessary to collect up to 4.5 % of blood
volume (about 4 ml/kg) to detect low concentrations of
pathogens in blood [31]. The methodology applied in
our study determined a volume of 1.5 ml of whole blood,
regardless of patient weight. When considering only
children and adolescents (as in our study), taking into
account the weight of each patient when determining
the volume of the sample to be collected would improve
the sensitivity of the method.
Conclusion
Real-time PCR applied directly to samples from positive
bloodstream bottles or whole blood samples constitutes
an accurate tool for the early identification of pathogens
and antimicrobial resistance genes in bloodstream
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infections of pediatric oncologic patients. In addition
to providing clinical data relevant to each individual
patient, these molecular results would be invaluable in
determining appropriate, patient-specific, antibiotic
therapy.
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